WallStSmart
CLPT

Clearpoint Neuro Inc

NASDAQ: CLPT · HEALTHCARE · MEDICAL DEVICES

$11.18
+8.12% today

Updated 2026-04-30

Market cap
$353.24M
P/E ratio
P/S ratio
9.55x
EPS (TTM)
$-0.90
Dividend yield
52W range
$8 – $30
Volume
0.8M

Clearpoint Neuro Inc (CLPT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-26.3%
Last 4 quarters
Revenue YoY growth
+34.0%
Most recent quarter
EPS YoY growth
-35.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-6.9%
2025-11-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-04$-0.27-45.9%$8.84$9.25+4.7%
2025-11-06$-0.21-16.7%$16.98$15.81-6.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.19$-0.27-45.9%$10.41M+34.0%
2025-09-30$-0.18$-0.21-16.7%$8.86M+9.1%
2025-06-30$-0.20$-0.21-5.0%$9.21M+17.3%
2025-03-31$-0.16$-0.22-37.5%$8.48M+11.1%
2024-12-31$-0.17$-0.20-15.1%$7.77M+14.1%
2024-09-30$-0.17$-0.18-5.9%$8.12M+41.0%
2024-06-30$-0.20$-0.16+20.0%$7.86M+32.1%
2024-03-31$-0.19$-0.16+15.8%$7.64M+40.6%
2023-12-31$-0.20$-0.19+5.0%$6.81M
2023-09-30$-0.25$-0.20+20.0%$5.76M
2023-06-30$-0.19$-0.29-52.6%$5.95M
2023-03-31$-0.18$-0.23-27.8%$5.43M

Frequently asked questions

Has Clearpoint Neuro Inc beaten earnings estimates?
Clearpoint Neuro Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -26.3% over the last 4 quarters.
How does CLPT stock react to earnings?
CLPT stock has moved an average of -1.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Clearpoint Neuro Inc's revenue growth rate?
Clearpoint Neuro Inc reported year-over-year revenue growth of +34.0% in its most recent quarter, with EPS growing -35.0% year-over-year.